Nph insulin and Ranitidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nph insulin (insulin susp isophane beef) and Ranitidine (ranitidine). Common drug interactions include neck pain among females and cardiac failure among males.

The phase IV clinical study analyzes what interactions people have when they take Nph insulin and Ranitidine. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Nph insulin?

Nph insulin has active ingredients of insulin susp isophane beef. It is often used in diabetes. eHealthMe is studying from 1,871 Nph insulin users. Check the latest studies of Nph insulin.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.



On Jul, 11, 2026

48 people who take Nph insulin and Ranitidine together, and have interactions are studied.

Nph insulin and Ranitidine drug interactions.

What are the common drug interactions of Nph Insulin and Ranitidine, by gender? *:

female:

  1. Neck pain
  2. Nervousness
  3. Oropharyngeal pain
  4. Pain
  5. Pain in extremity
  6. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  7. Pneumonia
  8. Pruritus (severe itching of the skin)
  9. Rash erythematous (redness of the skin)
  10. Renal injury (kidney injury)

male:

  1. Cardiac failure
  2. Hypotension (abnormally low blood pressure)
  3. Dyspnoea (difficult or laboured respiration)
  4. Epistaxis (bleed from the nose)
  5. Haemoglobin decreased
  6. Osteomyelitis (infection of bone)
  7. Platelet count increased
  8. Pneumonia
  9. Throat irritation
  10. White blood cell count increased

What are the common drug interactions of Nph Insulin and Ranitidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Hyperglycaemia (high blood sugar)

20-29:

n/a

30-39:

  1. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  2. Migraine (headache)
  3. Type 2 diabetes mellitus
  4. Dizziness
  5. Headache (pain in head)
  6. Asthma
  7. Cold sweat
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  9. Abasia (inability to walk)
  10. Alopecia (absence of hair from areas of the body)

40-49:

  1. Cardiac disorder
  2. Chills (felling of cold)
  3. Decreased appetite
  4. Depression
  5. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  6. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  7. Dizziness
  8. Drug hypersensitivity
  9. Dry eye (lack of adequate tears)
  10. Dry mouth

50-59:

  1. Pancreatitis (inflammation of pancreas)
  2. Diabetic gastropathy (gastric neuromuscular dysfunction in diabetes mellitus)
  3. Nausea (feeling of having an urge to vomit)
  4. Oral intake reduced
  5. Pallor
  6. Toothache (tooth pain)
  7. Vomiting
  8. Cellulitis (infection under the skin)
  9. Cardiac failure congestive
  10. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)

60+:

  1. Cardiac failure
  2. Hypotension (abnormally low blood pressure)
  3. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  4. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  5. Cough
  6. Dyspnoea (difficult or laboured respiration)
  7. Epistaxis (bleed from the nose)
  8. Haemoglobin decreased
  9. Osteomyelitis (infection of bone)
  10. Platelet count increased

What are the existing conditions these people have? *

  1. High Blood Pressure: 16 people, 33.33%
  2. Type 2 Diabetes: 10 people, 20.83%
  3. Indigestion: 7 people, 14.58%
  4. Blood Glucose Increased: 7 people, 14.58%
  5. Pain: 5 people, 10.42%
  6. Nausea (feeling of having an urge to vomit): 5 people, 10.42%
  7. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 5 people, 10.42%
  8. Stress And Anxiety: 4 people, 8.33%
  9. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 8.33%
  10. Dyslipidaemia (abnormal amount of lipids): 4 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Nph insulin and Ranitidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nph insulin and Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nph insulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nph insulin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranitidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin susp isophane beef and ranitidine (the active ingredients of Nph insulin and Ranitidine, respectively), and Nph insulin and Ranitidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: